Anxiety News and Research

Latest Anxiety News and Research

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Pfizer Inc. (NYSE:PFE) announced top-line results from two phase 3b, placebo-controlled studies with Lyrica® (pregabalin) Capsules CV in patients with fibromyalgia (FM) and painful diabetic peripheral neuropathy (DPN), respectively.

19 Oct 2013

Medicaid 'coverage gap' causing anxiety in non-expansion states, especially in the south

In states that decide not to expand Medicaid under the health law, more than 5 million people may be left without coverage. Oregon's expansion has already lowered the number of people there without coverage. Exchange issues are also examined in Maryland, Florida, Ohio and Alabama.

19 Oct 2013

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir). Levemir® FlexTouch® has been designed to improve ease of use for insulin administration and to help decrease barriers to good treatment adherence for Canadians living with type 1 and type 2 diabetes mellitus (diabetes).

19 Oct 2013

CBT more effective in reducing symptoms of health anxiety

Cognitive behavioural therapy (CBT) is substantially more effective than standard care at reducing symptoms of health anxiety in medical patients, and can be delivered by non-specialist staff with minimal training at little extra cost.

19 Oct 2013

Mindfulness-based intervention leads to drop in blood pressure

Blood pressure is effectively lowered by mindfulness-based stress reduction for patients with borderline high blood pressure or "prehypertension." This finding is reported in the October issue of Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.

16 Oct 2013

Ghrelin hormone released during chronic stress may predispose people to PTSD

About a dozen years ago, scientists discovered that a hormone called ghrelin enhances appetite. Dubbed the "hunger hormone," ghrelin was quickly targeted by drug companies seeking treatments for obesity - none of which have yet panned out.

16 Oct 2013

Binge drinking during pregnancy linked to negative emotions

Researchers in Norway found that negative affectivity is linked to light alcohol use and binge drinking during pregnancy. Results published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, show 16% of women had light alcohol use in the first trimester and 10% in the second trimester.

15 Oct 2013

Pregabalin drug can help reduce incidence of chronic pain following cardiac surgery

The incidence of chronic pain following cardiac surgery can be reduced in patients when the drug pregabalin is used before surgery and for 14 days post-surgery, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

Study: Depression in Parkinson's patients may reflect impaired striatal dopamine function

According to the Parkinson's Disease Foundation, up to 60% of individuals with Parkinson's disease (PD) exhibit mild to moderate depression, which is often underdiagnosed.

11 Oct 2013

Natural painkiller system in the brain responds to social rejection

"Sticks and stones may break my bones, but words will never hurt me," goes the playground rhyme that's supposed to help children endure taunts from classmates. But a new study suggests that there's more going on inside our brains when someone snubs us - and that the brain may have its own way of easing social pain.

11 Oct 2013

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration has accepted and filed the company's supplemental Biologics License Application for subcutaneous use of Xolair (omalizumab) in people with Chronic Idiopathic Urticaria who remained symptomatic despite treatment with H1-antihistamine therapy at approved doses.

11 Oct 2013

Crucial role of orthopedic surgeons in diagnosing mTBI among trauma care patients

In the United States, approximately 1.4 million people suffer a traumatic brain injury (TBI) each year. Of those injuries, three out of four are minor TBI (mTBI)-a head injury that causes a temporary change in mental status including confusion, an altered level of consciousness, or perceptual or behavioral impairments.

11 Oct 2013

Depression in Parkinson's disease people associated with reduced dopamine synthesis capacity

According to the Parkinson's Disease Foundation, up to 60% of individuals with Parkinson's disease exhibit mild to moderate depression, which is often underdiagnosed. It is unclear whether depression results from having a debilitating disease or reflects a parallel abnormal change in the brain caused by PD pathophysiology.

11 Oct 2013

Transcendental Meditation technique has large effect on reducing trait anxiety, shows analysis

A new meta-analysis published today in the Journal of Alternative and Complementary Medicine (2013;19(10):1-12)1 found the Transcendental Meditation- technique (TM) has a large effect on reducing trait anxiety for people with high anxiety.

10 Oct 2013

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.

10 Oct 2013

Slow caress or stroke may play part in creating, sustaining positive sense of self

A loving touch, characterized by a slow caress or stroke - often an instinctive gesture from a mother to a child or between partners in romantic relationships - may increase the brain's ability to construct a sense of body ownership and, in turn, play a part in creating and sustaining a healthy sense of self.

9 Oct 2013

Flumazenil reverses stress-triggered anxiety in methamphetamine dependant rats

SUNY Downstate Medical Center announced today that Sheryl Smith, PhD, professor of physiology and pharmacology, has published new findings demonstrating a reproducible pathology that may help shed light on anxiety and mood volatility in methamphetamine dependence.

9 Oct 2013

Binge eating disorder is different from anorexia nervosa and bulimia nervosa

Food addiction is not yet recognised as a mental disorder but certain obese individuals clearly display addictive-like behaviour towards food.

9 Oct 2013

Online health information affects people who cannot tolerate uncertainty

Turning to the Internet to find out what ails you is common, but for folks who have trouble handling uncertainty, "cyberchondria" - the online counterpart to hypochondria - worsens as they seek answers, a Baylor University researcher says.

9 Oct 2013

UCLA investigates high rates of schizophrenia in people with 22q11.2 deletion syndrome

UCLA has joined an international consortium to investigate the high rates of schizophrenia and other neuropsychiatric disorders in those who are affected with Chromosome 22q11.2 deletion syndrome, a disorder caused by the deletion of a small piece of chromosome number 22.

9 Oct 2013

Anxiety News and Research

Latest Anxiety News and Research

Pfizer announces top-line results from phase 3b studies with Lyrica Capsules

Medicaid 'coverage gap' causing anxiety in non-expansion states, especially in the south

Levemir FlexTouch insulin pen receives approval from Health Canada for treatment of diabetes

CBT more effective in reducing symptoms of health anxiety

Mindfulness-based intervention leads to drop in blood pressure

Ghrelin hormone released during chronic stress may predispose people to PTSD

Binge drinking during pregnancy linked to negative emotions

Pregabalin drug can help reduce incidence of chronic pain following cardiac surgery

Study: Depression in Parkinson's patients may reflect impaired striatal dopamine function

Natural painkiller system in the brain responds to social rejection

FDA accepts, files Genentech's sBLA for subcutaneous use of Xolair in people with CIU

Crucial role of orthopedic surgeons in diagnosing mTBI among trauma care patients

Depression in Parkinson's disease people associated with reduced dopamine synthesis capacity

Transcendental Meditation technique has large effect on reducing trait anxiety, shows analysis

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

Slow caress or stroke may play part in creating, sustaining positive sense of self

Flumazenil reverses stress-triggered anxiety in methamphetamine dependant rats

Binge eating disorder is different from anorexia nervosa and bulimia nervosa

Online health information affects people who cannot tolerate uncertainty

UCLA investigates high rates of schizophrenia in people with 22q11.2 deletion syndrome

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Anxiety News and Research

Latest Anxiety News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in